GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADORA1, AKR1B1, APEX1, AURKB, AXL, BCL2, CA12, CA2, CA7, CHRM1, CHRM3, CHRNA3, CHRNA7, CYP19A1, CYP1A1, CYP1B1, EDNRA, FABP3, FABP4, FLT3, GAA, GRIA2, GRIA4, GRIK5, GRM1, GRM5, HCAR2, HSD17B1, HSD17B2, KDR, MET, PPARA, SLC1A1, SRC, XDH |
8.06534 |
[BP] GO:0007193 |
None
|
ADORA1, CHRM1, CHRM2, CHRM3, CHRM5, GRM1, GRM3, GRM5, GRM8 |
8.06534 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, APEX1, AXL, BCL2, CA9, CHRNA3, CHRNA7, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, FABP3, GRIK5, GRM5, HSD17B2, IGF1R, MMP2, MMP9, PPARA, RORC, SRC, TYR |
7.87352 |
[BP] GO:0095500 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5, CHRNA3, CHRNA7 |
6.97605 |
[BP] GO:1903831 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5, CHRNA3, CHRNA7 |
6.97605 |
[BP] GO:0007215 |
None
|
GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
6.97605 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.97605 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, ALPL, APEX1, AXL, BCL2, CA2, CA9, CHRNA3, CHRNA7, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FLT3, GRIK5, GRM5, HSD17B2, IGF1R, KDR, MMP2, PPARA, RORC, SRC, TYR |
6.79531 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, BCL2, CYP1A1, CYP1A2, CYP1B1, TYR |
6.60051 |
[BP] GO:0007197 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
6.41326 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AXL, BCL2, CHRM1, CHRM3, CHRM5, CHRNA3, CHRNA7, CYP19A1, CYP1A2, CYP1B1, EDNRA, FABP4, GAA, GRM1, GRM5, GRM8, HSD17B2, IGF1R, MET, MGAM, MMP1, MMP2, MMP9, PIM1, PPARA, RORC, SRC, TYR |
6.36214 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, APEX1, AURKB, AXL, BCL2, CHRNA7, CSNK2A1, CYP1B1, FLT3, GLO1, GRIK5, HCAR2, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PTPN1, SRC, TOP2A, XDH |
6.31213 |
[BP] GO:0007207 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
5.99491 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7, CA9 |
5.96265 |
[BP] GO:0007188 |
None
|
ADORA1, CHRM1, CHRM2, CHRM3, CHRM5, GRM1, GRM3, GRM5, GRM8 |
5.92952 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, AKR1B1, ALPL, APEX1, AURKB, AXL, BCL2, CA2, CA9, CDC25B, CHRM1, CHRM2, CHRM3, CHRNA3, CHRNA7, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EDNRA, FABP4, FLT3, FUT7, GAA, GLO1, HSD17B2, KDR, MET, MMP2, MMP9, PIM1, PPARA, RORC, SRC, TOP2A, TYR |
5.8628 |
[BP] GO:0007268 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5, CHRNA3, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1 |
5.8628 |
[BP] GO:0098916 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5, CHRNA3, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1 |
5.8628 |
[BP] GO:0099536 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5, CHRNA3, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1 |
5.77752 |
[BP] GO:0099537 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5, CHRNA3, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1 |
5.77752 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, CA2, CA7, CHRNA3, CHRNA7, GRIK5, GRM1, GRM3, GRM5, GRM8 |
5.76848 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, CA2, CA7, CHRNA3, CHRNA7, GRIK5, GRM1, GRM3, GRM5, GRM8 |
5.76848 |
[BP] GO:0042221 |
response to chemical
|
AKR1B1, ALPL, APEX1, AXL, BCL2, CA2, CA9, CHRNA3, CHRNA7, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FLT3, GRIK5, GRM5, HSD17B2, IGF1R, KDR, MMP2, MMP9, PPARA, RORC, SRC, TYR |
5.75338 |
[BP] GO:0060078 |
None
|
ADORA1, CHRNA3, CHRNA7, GRIA2, GRIA4, GRIK5, GRM5 |
5.55725 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, APEX1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, FLT3, GLO1, GRIK5, HCAR2, IGF1R, KDR, MET, MMP9, PIM1, PTPN1, SRC, TOP2A, XDH |
5.49635 |
[BP] GO:0007187 |
None
|
ADORA1, CHRM1, CHRM2, CHRM3, CHRM5, GRM1, GRM3, GRM5, GRM8 |
5.43862 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, ALPL, APEX1, BCL2, CA2, CA9, CHRNA3, CHRNA7, CSNK2A1, CYP1A2, FABP3, FLT3, GRM5, IGF1R, MMP2, PPARA, SRC |
5.32747 |
[BP] GO:0007196 |
None
|
GRM1, GRM3, GRM5, GRM8 |
5.2455 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, ALPL, APEX1, BCL2, CA2, CA9, CHRNA3, CHRNA7, CSNK2A1, CYP1A2, FABP3, FLT3, PPARA, SRC |
5.05798 |
[BP] GO:0007271 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5, CHRNA3 |
4.99824 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, APEX1, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, FABP4, KDR, MMP9, SRC |
4.95716 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, APEX1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, FLT3, GLO1, GRIK5, HCAR2, IGF1R, KDR, MMP9, PIM1, PTPN1, SRC, TOP2A, XDH |
4.88051 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, AKR1B1, APEX1, AXL, BCL2, CA12, CA2, CA7, CHRNA7, EDNRA, FABP3, FABP4, FLT3, GAA, GRIK5, GRM1, GRM5, MET, SRC |
4.84155 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALOX5, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FUT7, GAA, GLO1, PIM1, PPARA, TYR, XDH |
4.69116 |
[BP] GO:0033993 |
response to lipid
|
ALPL, AXL, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, FABP3, FLT3, HSD17B2, RORC, SRC, TYR |
4.64294 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, BCL2, CDC25B, CHRM5, CHRNA3, CHRNA7, EDNRA, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MMP9, PPARA, PTPN1, SRC, XDH |
4.61789 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, AKR1B1, APEX1, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CHRM1, CHRM3, CHRNA3, CHRNA7, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, FABP3, FABP4, FLT3, GRIK5, GRM1, GRM5, HCAR2, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SLC1A1, SRC, TOP2A, XDH |
4.57897 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, BCL2, CDC25B, CHRM5, CHRNA3, CHRNA7, EDNRA, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MMP9, PPARA, PTPN1, SRC, XDH |
4.57897 |
[BP] GO:0060079 |
None
|
ADORA1, CHRNA3, CHRNA7, GRIA2, GRIA4, GRIK5 |
4.49119 |
[BP] GO:0007216 |
None
|
GRM1, GRM3, GRM5, GRM8 |
4.4801 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.37413 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, AKR1B1, APEX1, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CHRM1, CHRNA3, CHRNA7, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, FABP3, FLT3, GRIK5, GRM1, GRM5, HCAR2, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SRC, TOP2A, XDH |
4.33937 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AURKB, BCL2, CHRM1, CHRM3, CHRM5, CYP1A1, EDNRA, FLT3, MET, PIM1, SRC, TYR |
4.3224 |
[BP] GO:0007213 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
4.2543 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FUT7, HSD17B1, HSD17B2, MET, PPARA |
4.21026 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, AKR1B1, AXL, BCL2, CA1, CA2, CHRM1, CHRM2, CHRM3, CHRM5, CHRNA3, CHRNA7, CSNK2A1, CYP1B1, EDNRA, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, KDR, MET, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SRC |
4.16176 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, GLO1, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PTPN1, SRC |
4.07244 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, APEX1, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, FLT3, RORC, SRC, TYR |
3.87117 |
[BP] GO:0007154 |
None
|
ADORA1, AXL, BCL2, CHRM1, CHRM2, CHRM3, CHRM5, CHRNA3, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1 |
3.81212 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, GLO1, IGF1R, KDR, MET, MMP9, PIM1, PTPN1, SRC |
3.81212 |
[BP] GO:0042391 |
None
|
ADORA1, BCL2, CHRNA3, CHRNA7, GRIA2, GRIA4, GRIK5, GRM5, KDR, SRC |
3.81212 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, APEX1, AXL, BCL2, CHRNA7, CYP1A1, CYP1B1, KDR, SRC |
3.79731 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, AKR1B1, AXL, BCL2, CA2, CA7, CHRNA7, CSNK2A1, CYP19A1, CYP1B1, FLT3, GRM1, HCAR2, KDR, MET, MMP9, PTPN1, SRC, XDH |
3.76273 |
[BP] GO:0007267 |
None
|
ADORA1, CHRM1, CHRM2, CHRM3, CHRM5, CHRNA3, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1 |
3.76184 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, ALPL, APEX1, AXL, BCL2, CYP1A1, CYP1A2, CYP1B1, FABP4, FLT3, GRIK5, GRM5, IGF1R, KDR, MMP2, MMP9, RORC, SRC |
3.74893 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, AKR1B1, AXL, BCL2, CA2, CA7, CHRNA7, CSNK2A1, CYP19A1, CYP1B1, FLT3, GRM1, HCAR2, KDR, MET, MMP9, PTPN1, SRC, XDH |
3.74893 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, AKR1B1, ALPL, AXL, BCL2, CA2, CHRM1, CHRM2, CHRM3, CHRNA3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EDNRA, FLT3, GAA, HSD17B2, KDR, MMP9, PIM1, PPARA, RORC, SRC, TYR |
3.70563 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, FABP3, PPARA, SLC1A1 |
3.68084 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.63646 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, ALPL, APEX1, AURKB, AXL, BCL2, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, FABP4, FLT3, GRIK5, GRM1, GRM5, IGF1R, KDR, MMP2, MMP9, PTPN1, RORC, SRC, TOP2A |
3.60887 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA1, ADORA3, AKR1B1, ALPL, APEX1, AURKB, AXL, BCL2, CA2, CA9, CHRM2, CHRNA3, CHRNA7, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EDNRA, FABP3, FABP4, FLT3, GRIK5, GRM1, GRM5, HSD17B2, IGF1R, KDR, MMP2, MMP9, PPARA, PTPN1, RORC, SRC, TOP2A, TYR |
3.56503 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, ALPL, APEX1, AXL, BCL2, CYP1A1, CYP1B1, FABP4, FLT3, GRIK5, GRM5, IGF1R, KDR, MMP2, RORC, SRC |
3.56503 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HSD17B1, HSD17B2 |
3.54743 |
[BP] GO:0051966 |
regulation of synaptic transmission, glutamatergic
|
ADORA1, GRM1, GRM3, GRM5, GRM8 |
3.54743 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, BCL2, CYP1B1, SRC |
3.54743 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, HSD17B1, HSD17B2 |
3.54743 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, APEX1, AXL, CYP1B1, MMP9, SRC |
3.54743 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, APEX1, AXL, BCL2, CYP1B1, MMP9, SRC |
3.51106 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, BCL2, CHRNA7, CYP1A1, EDNRA, MMP2, PPARA, SRC |
3.43925 |
[BP] GO:0006940 |
None
|
ADORA1, CHRM1, CHRM2, CHRM3, CHRNA3 |
3.37807 |
[BP] GO:0023052 |
None
|
ADORA1, CHRM1, CHRM2, CHRM3, CHRM5, CHRNA3, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1 |
3.37765 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, AKR1B1, AURKB, AXL, BCL2, CA2, CA7, CHRNA3, CHRNA7, CSNK2A1, CYP19A1, CYP1B1, FLT3, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, KDR, MET, MMP9, PTPN1, SRC, XDH |
3.37178 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, HSD17B1, HSD17B2 |
3.37178 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, BCL2, CHRNA7, CYP1A1, EDNRA, MMP2, PPARA, SRC |
3.35945 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, CHRM5, CYP1A1, FABP3, FLT3, HCAR2, PPARA, RORC, SRC |
3.33623 |
[BP] GO:0007166 |
cell surface receptor signaling pathway
|
ADORA1, ADORA3, AXL, BCL2, CA1, CSNK2A1, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, MMP2, MMP9, PTPN1, SRC |
3.336 |
[BP] GO:0009987 |
cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, AKR1B10, ALOX5, ALPL, APEX1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CHRM1, CHRM2, CHRM3, CHRM5, CHRNA3, CHRNA7, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EDNRA, FABP3, FABP4, FLT3, FUT7, GAA, GLO1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HSD17B1, HSD17B2, IGF1R, KDR, MET, MGAM, MMP1, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SLC1A1, SRC, TOP2A, TYR, XDH |
3.31764 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, AKR1B1, AURKB, AXL, BCL2, CA2, CA7, CHRNA3, CHRNA7, CSNK2A1, CYP19A1, CYP1B1, FLT3, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, KDR, MET, MMP9, PTPN1, SRC, XDH |
3.29123 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, AKR1B1, BCL2, CDC25B, CHRM1, CHRNA7, CSNK2A1, CYP1B1, FABP3, FLT3, IGF1R, KDR, MMP2, MMP9, PIM1, SRC, XDH |
3.28675 |
[BP] GO:0006811 |
None
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, CHRM5, CHRNA3, CHRNA7, FABP3, GRIA2, GRIA4, GRIK5, PPARA, SLC1A1 |
3.27843 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, GLO1, IGF1R, KDR, MMP9, PIM1, PTPN1, SRC |
3.27131 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, FLT3, IGF1R, KDR, PIM1, SRC |
3.24055 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, AURKB, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FUT7, GAA, MGAM, MMP1, MMP2, MMP9, SRC, XDH |
3.22521 |
[BP] GO:0042493 |
response to drug
|
AKR1B1, APEX1, AXL, BCL2, CA9, CHRNA3, CHRNA7, CYP1A1, CYP1B1, FABP3, KDR, SRC |
3.19768 |
[BP] GO:2001225 |
regulation of chloride transport
|
CA2, CA7, GRM5 |
3.19768 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.19768 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, APEX1, AXL, BCL2, CA2, CA7, CHRM1, CHRNA3, CSNK2A1, CYP19A1, CYP1B1, GRIK5, GRM5, HCAR2, IGF1R, KDR, MET, MMP9, PPARA, PTPN1, SRC |
3.14646 |
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, BCL2, CHRNA7, CYP1A1, EDNRA, MMP2, PPARA, SRC |
3.14062 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AXL, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, EDNRA, FLT3, HSD17B2, KDR, PPARA, SRC, TYR |
3.12544 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX5, APEX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, GAA, HSD17B1, HSD17B2, TYR, XDH |
3.08872 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, AKR1B1, CHRNA3, CYP19A1, CYP1A1, CYP1B1, HCAR2, HSD17B1, HSD17B2 |
3.07924 |
[BP] GO:0044057 |
None
|
ADORA1, ADORA3, CHRM1, CHRM2, CHRM3, CHRNA3, GAA, GRM1, HCAR2, SLC1A1 |
3.0111 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.85788 |
[BP] GO:0048878 |
chemical homeostasis
|
AKR1B1, BCL2, CA12, CA2, CA7, CHRNA7, EDNRA, FABP3, FABP4, GRIK5, GRM1, GRM5, MET |
2.85788 |
[BP] GO:0007200 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5, GRM5 |
2.85418 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, BCL2, CDC25B, CHRNA3, CHRNA7, FLT3, GRM1, GRM5, KDR, MMP9, PTPN1, SRC, XDH |
2.85396 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, FABP3, PPARA, SLC1A1 |
2.8448 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, BCL2, CDC25B, CHRNA3, CHRNA7, FABP3, FLT3, GRM1, GRM5, KDR, MMP9, PTPN1, SRC, XDH |
2.8448 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, BCL2, CDC25B, CHRNA3, CHRNA7, FABP3, FLT3, GRM1, GRM5, KDR, MMP9, PTPN1, SRC, XDH |
2.8448 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APEX1, CHRNA3, CHRNA7, FABP3, FLT3, GRM5, IGF1R, MMP2, PPARA, SRC, TYR |
2.76861 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, AKR1B1, AXL, BCL2, CHRNA7, CYP1B1, FLT3, GRM1, KDR, MET, PTPN1, SRC, XDH |
2.72397 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, BCL2, CDC25B, CHRNA3, CHRNA7, FLT3, GRM1, GRM5, KDR, MMP9, PTPN1, SRC, XDH |
2.6743 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, APEX1, CHRNA7, FABP3, GRM5, IGF1R, PPARA, SRC |
2.62814 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, AURKB, BCL2, CA2, CHRNA7, CYP1A1, EDNRA, GRM1, MMP2, PPARA, SRC, TYR |
2.61533 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, BCL2, CDC25B, CHRNA3, CHRNA7, FABP4, FLT3, GRM1, GRM5, IGF1R, KDR, MMP9, PPARA, PTPN1, SRC, XDH |
2.58679 |
[BP] GO:0065007 |
biological regulation
|
ACHE, ADORA1, ADORA3, AKR1B1, APEX1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA7, CA9, CDC25B, CHRM1, CHRM2, CHRM3, CHRM5, CHRNA3, CHRNA7, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EDNRA, FABP3, FABP4, FLT3, GAA, GLO1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HSD17B1, HSD17B2, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SLC1A1, SRC, TOP2A, XDH |
2.58102 |
[BP] GO:0002521 |
leukocyte differentiation
|
AXL, BCL2, FLT3, FUT7, GLO1, MMP9, RORC |
2.53671 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, BCL2, CDC25B, CHRM1, CHRNA7, CSNK2A1, FLT3, IGF1R, KDR, MMP2, MMP9, PIM1 |
2.48633 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, APEX1, BCL2, CHRM1, CYP19A1, CYP1B1, IGF1R, KDR, MET, MMP9, SRC |
2.4601 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, CYP19A1, CYP1A2, CYP1B1, FABP3, FABP4 |
2.45536 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, BCL2, CDC25B, CHRNA3, CHRNA7, FABP4, FLT3, GRM1, GRM5, IGF1R, KDR, MMP9, PTPN1, SRC, XDH |
2.43939 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, APEX1, AXL, CYP1B1, GRIK5, GRM5, IGF1R, MMP2, MMP9, RORC, SRC |
2.43373 |
[BP] GO:0003008 |
None
|
ADORA1, AKR1B1, BCL2, CHRM1, CHRM3, CHRM5, CHRNA7, CYP1B1, EDNRA, GAA, GRM1, GRM5, GRM8, SRC, TYR |
2.42603 |
[BP] GO:0051900 |
regulation of mitochondrial depolarization
|
BCL2, KDR, SRC |
2.42603 |
[BP] GO:0099566 |
None
|
GRM1, GRM5 |
2.42603 |
[BP] GO:0000023 |
None
|
GAA, MGAM |
2.42603 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.42603 |
[BP] GO:1905144 |
None
|
CHRNA3, CHRNA7 |
2.42603 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APEX1, CHRNA7, FABP3, FLT3, GRM5, IGF1R, MMP2, PPARA, SRC, TYR |
2.42603 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.42603 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, FLT3, IGF1R, KDR, MET, MMP2, MMP9, PTPN1, SRC |
2.41508 |
[BP] GO:0006810 |
None
|
ACHE, ADORA1, ALOX5, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CHRM1, CHRM3, CHRM5, CHRNA3, CHRNA7, EDNRA, FABP3, GAA, GRIA2, GRIA4, GRIK5, MGAM, MMP9, PPARA, SLC1A1, SRC, XDH |
2.41508 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.39409 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, APEX1, BCL2, CYP19A1, CYP1B1, IGF1R, KDR, MET, MMP9, SRC |
2.37597 |
[BP] GO:0048511 |
rhythmic process
|
AXL, BCL2, CSNK2A1, PPARA, RORC, SRC, TOP2A |
2.36375 |
[BP] GO:1903522 |
None
|
ADORA1, ADORA3, CHRM1, CHRM2, CHRM3, GAA, SLC1A1 |
2.35633 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, APEX1, AXL, CYP1B1, MMP9, SRC |
2.34209 |
[BP] GO:0045860 |
positive regulation of protein kinase activity
|
ADORA1, CDC25B, CHRNA3, CHRNA7, FLT3, GRM1, GRM5, PTPN1, SRC |
2.33328 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
2.32483 |
[BP] GO:0045859 |
regulation of protein kinase activity
|
ADORA1, CDC25B, CHRNA3, CHRNA7, FABP4, FLT3, GRM1, GRM5, IGF1R, PTPN1, SRC |
2.30373 |
[BP] GO:0097237 |
cellular response to toxic substance
|
AKR1B1, APEX1, AXL, CYP1B1, KDR |
2.30247 |
[BP] GO:0070301 |
cellular response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, CYP1B1 |
2.28995 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, HSD17B1, HSD17B2 |
2.28995 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CHRNA7, CSNK2A1, CYP1B1, FLT3, GRM1, IGF1R, KDR, MET, MMP9, PTPN1, SRC, XDH |
2.25055 |
[BP] GO:0043393 |
regulation of protein binding
|
AURKB, BCL2, MET, MMP9, PPARA, SRC |
2.22635 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.21788 |
[BP] GO:0007186 |
G-protein coupled receptor signaling pathway
|
ADORA1, ADORA3, CA2, CHRM1, CHRM2, CHRM3, CHRM5, EDNRA, GRM1, GRM3, GRM5, GRM8, HCAR2, SRC |
2.21638 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX5, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FUT7, MET, PPARA |
2.20563 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, BCL2, CA2, CA7, KDR, SRC |
2.20204 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.18595 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.17992 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, ALPL, APEX1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CHRM1, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FLT3, FUT7, GAA, GLO1, HSD17B1, HSD17B2, IGF1R, KDR, MET, MGAM, MMP1, MMP2, PIM1, PPARA, PTPN1, RORC, SRC, TOP2A, TYR, XDH |
2.17984 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, APEX1, BCL2, CYP19A1, CYP1B1, IGF1R, KDR, MET, MMP9, SRC |
2.17503 |
[BP] GO:0033674 |
positive regulation of kinase activity
|
ADORA1, CDC25B, CHRNA3, CHRNA7, FLT3, GRM1, GRM5, PTPN1, SRC |
2.16344 |
[BP] GO:0051347 |
positive regulation of transferase activity
|
ADORA1, AURKB, CDC25B, CHRNA3, CHRNA7, FLT3, GRM1, GRM5, PTPN1, SRC |
2.15115 |
[BP] GO:0042180 |
None
|
AKR1B1, AKR1B10, CYP19A1, GLO1 |
2.119 |
[BP] GO:0051234 |
None
|
ACHE, ADORA1, ALOX5, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CHRM1, CHRM3, CHRM5, CHRNA3, CHRNA7, EDNRA, FABP3, GAA, GRIA2, GRIA4, GRIK5, MGAM, MMP9, PPARA, SLC1A1, SRC, XDH |
2.10234 |
[BP] GO:0035235 |
None
|
GRIA2, GRIA4, GRIK5 |
2.09338 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, AKR1B1, AXL, BCL2, CHRNA7, CSNK2A1, CYP1B1, FLT3, GRM1, KDR, MET, MMP9, PTPN1, SRC, XDH |
2.08752 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, AURKB, CSNK2A1, CYP1B1, FABP4, GRM3, IGF1R, MET, MMP9, PIM1, PPARA, PTPN1, SRC |
2.08417 |
[BP] GO:1900543 |
None
|
EDNRA, GRM3, GRM8, PPARA |
2.08417 |
[BP] GO:0043549 |
regulation of kinase activity
|
ADORA1, CDC25B, CHRNA3, CHRNA7, FABP4, FLT3, GRM1, GRM5, IGF1R, PTPN1, SRC |
2.0803 |
[BP] GO:0048731 |
system development
|
ACHE, ADORA1, ALPL, CHRM1, CHRM2, CHRM3, CHRNA3, EDNRA, MMP9, SRC |
2.07944 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, AURKB, BCL2, CDC25B, CHRNA3, CHRNA7, CSNK2A1, EDNRA, FABP4, FLT3, GRM1, GRM3, GRM5, IGF1R, MMP9, PTPN1, SRC, XDH |
2.07469 |
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
CHRM5, FABP3, FLT3, SRC |
2.07207 |
[BP] GO:0045980 |
None
|
EDNRA, GRM3, GRM8, PPARA |
2.07207 |
[BP] GO:0050789 |
regulation of biological process
|
ACHE, ADORA1, ADORA3, AKR1B1, APEX1, AURKB, AXL, BCL2, CA1, CA2, CA7, CA9, CDC25B, CHRM1, CHRM2, CHRM3, CHRM5, CHRNA3, CHRNA7, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EDNRA, FABP3, FABP4, FLT3, GAA, GLO1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SLC1A1, SRC, TOP2A, XDH |
2.06719 |
[BP] GO:0051338 |
regulation of transferase activity
|
ADORA1, AURKB, CDC25B, CHRNA3, CHRNA7, FABP4, FLT3, GRM1, GRM5, IGF1R, PTPN1, SRC |
2.05558 |
[BP] GO:0046541 |
None
|
CHRM1, CHRM3 |
2.01778 |
[CC] GO:0098590 |
plasma membrane region
|
ADORA1, CA2, CA4, CA9, CHRM1, CHRM2, CHRM3, CHRM5, CHRNA3, CHRNA7, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, MET, MGAM, SLC1A1, SRC |
8.06534 |
[CC] GO:0097060 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5, CHRNA3, CHRNA7, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
7.76685 |
[CC] GO:0005886 |
plasma membrane
|
ACHE, ADORA1, ADORA3, ALPL, AXL, CA12, CA14, CA2, CA4, CA9, CHRM1, CHRM2, CHRM3, CHRM5, CHRNA3, CHRNA7, CSNK2A1, EDNRA, FLT3, GAA, GLO1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, KDR, MET, MGAM, MMP2, PIM1, PTPN1, SLC1A1, SRC |
6.79531 |
[CC] GO:0044456 |
None
|
ACHE, ADORA1, CHRM1, CHRM2, CHRM3, CHRM5, CHRNA3, CHRNA7, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, SRC |
6.41326 |
[CC] GO:0045211 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5, CHRNA3, CHRNA7, GRIA2, GRIA4, GRIK5, GRM3 |
5.99491 |
[CC] GO:0044459 |
plasma membrane part
|
ADORA1, ADORA3, AXL, CA2, CA4, CA9, CHRM1, CHRM2, CHRM3, CHRM5, CHRNA3, CHRNA7, EDNRA, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, MGAM, SLC1A1, SRC |
5.1191 |
[CC] GO:0016020 |
membrane
|
ACHE, ADORA1, ADORA3, ALOX5, ALPL, AXL, BCL2, CA12, CA14, CA2, CA4, CA9, CHRM1, CHRM2, CHRM3, CHRM5, CHRNA3, CHRNA7, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EDNRA, FLT3, FUT7, GAA, GLO1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HSD17B2, IGF1R, KDR, MET, MGAM, MMP2, PIM1, PTPN1, SLC1A1, SRC, TYR |
4.80754 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA1, ADORA3, AXL, CA4, CHRM1, CHRM2, CHRM3, CHRM5, EDNRA, FLT3, GRIA2, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, SLC1A1 |
4.40726 |
[CC] GO:0014069 |
None
|
ADORA1, CHRM1, CHRNA3, GRIK5, GRM1, GRM3, GRM5, SRC |
4.13988 |
[CC] GO:0099572 |
None
|
ADORA1, CHRM1, CHRNA3, GRIK5, GRM1, GRM3, GRM5, SRC |
4.13988 |
[CC] GO:0005887 |
integral component of plasma membrane
|
ADORA1, ADORA3, AXL, CHRM1, CHRM2, CHRM3, CHRM5, EDNRA, FLT3, GRIA2, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, SLC1A1 |
4.0314 |
[CC] GO:0044425 |
membrane part
|
ACHE, ADORA1, ADORA3, ALPL, AXL, BCL2, CA12, CA14, CA2, CA4, CA9, CHRM1, CHRM2, CHRM3, CHRM5, CHRNA3, CHRNA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EDNRA, FLT3, FUT7, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HSD17B2, IGF1R, KDR, MET, MGAM, PTPN1, SLC1A1, SRC, TYR |
3.70563 |
[CC] GO:0043005 |
None
|
ADORA1, CA2, CHRM1, CHRM2, CHRM3, CHRNA3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, SRC |
3.54743 |
[CC] GO:0042734 |
None
|
GRIK5, GRM1, GRM3, GRM5, GRM8 |
3.47326 |
[CC] GO:0098802 |
None
|
CHRNA3, CHRNA7, GRIA2, GRIA4, GRIK5, GRM1 |
2.53913 |
[CC] GO:0120025 |
None
|
ADORA1, AKR1B1, CA2, CHRM1, CHRM2, CHRM3, CHRNA3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, SRC |
2.16712 |
[CC] GO:0043235 |
receptor complex
|
CHRNA3, CHRNA7, GRIA2, GRIA4, GRIK5, GRM1, IGF1R |
2.08752 |
[CC] GO:0030425 |
None
|
CHRM1, CHRM2, CHRM3, CHRNA3, GRIA2, GRIK5, GRM1 |
2.01708 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
9.4179 |
[MF] GO:0030594 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5, CHRNA3, CHRNA7, GRIA2, GRIA4, GRIK5, GRM1, GRM5 |
9.23771 |
[MF] GO:0008066 |
None
|
GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
8.06534 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, AXL, CHRM1, CHRM2, CHRM3, CHRM5, CHRNA3, CHRNA7, EDNRA, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, KDR, MET, PPARA, RORC |
8.06534 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX5, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, GLO1, MMP1, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, TYR, XDH |
7.65201 |
[MF] GO:0015464 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5, CHRNA3, CHRNA7 |
7.47364 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA1, ADORA3, AXL, CHRM1, CHRM2, CHRM3, CHRM5, CHRNA3, CHRNA7, EDNRA, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, KDR, MET |
7.37037 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA1, ADORA3, AXL, CHRM1, CHRM2, CHRM3, CHRM5, CHRNA3, CHRNA7, EDNRA, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, KDR, MET |
7.37037 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, APEX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CDC25B, CHRM1, CHRM3, CHRM5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EDNRA, FLT3, FUT7, GAA, GLO1, HSD17B1, HSD17B2, IGF1R, KDR, MET, MGAM, MMP1, MMP2, MMP9, PIM1, PTPN1, SRC, TOP2A, TYR, XDH |
7.31465 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, AXL, CHRM1, CHRM2, CHRM3, CHRM5, CHRNA3, CHRNA7, EDNRA, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, KDR, MET, PPARA, RORC |
7.31465 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, AXL, CHRM1, CHRM2, CHRM3, CHRM5, CHRNA3, CHRNA7, EDNRA, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, KDR, MET, PPARA, RORC |
7.05582 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.92408 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, AXL, CHRM1, CHRM2, CHRM3, CHRM5, CHRNA3, CHRNA7, EDNRA, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, KDR, MET, PPARA, RORC |
6.6365 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.41326 |
[MF] GO:0016907 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
6.41326 |
[MF] GO:0016829 |
lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, GLO1 |
5.42728 |
[MF] GO:0004629 |
None
|
ADORA1, CHRM1, CHRM3, CHRM5, EDNRA |
4.79458 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CHRM1, CHRM2, CHRM3, CHRNA3, CHRNA7, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FLT3, IGF1R, KDR, MET, PIM1, PPARA, SRC, TOP2A |
4.65514 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX5, ALPL, APEX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CHRM3, CHRNA3, CHRNA7, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FLT3, GLO1, HSD17B1, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SLC1A1, SRC, TOP2A, TYR, XDH |
4.59767 |
[MF] GO:0042166 |
None
|
ACHE, CHRM3, CHRNA3, CHRNA7 |
4.15683 |
[MF] GO:0042562 |
hormone binding
|
ACHE, CHRM3, CHRNA3, CHRNA7, HSD17B1, IGF1R |
4.0314 |
[MF] GO:0005231 |
None
|
CHRNA3, CHRNA7, GRIA2, GRIA4, GRIK5 |
3.88162 |
[MF] GO:0008081 |
None
|
ADORA1, APEX1, CHRM1, CHRM3, CHRM5, EDNRA |
3.87117 |
[MF] GO:0098960 |
None
|
CHRNA3, CHRNA7, GRM1, GRM5 |
3.81762 |
[MF] GO:0022824 |
None
|
CHRNA3, CHRNA7, GRIA2, GRIA4, GRIK5 |
3.81762 |
[MF] GO:0022835 |
None
|
CHRNA3, CHRNA7, GRIA2, GRIA4, GRIK5 |
3.81762 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.70563 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.53251 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX5, ALPL, APEX1, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CHRM3, CHRNA3, CHRNA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, GLO1, MMP1, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SLC1A1, TOP2A, TYR, XDH |
3.4898 |
[MF] GO:0004435 |
None
|
CHRM1, CHRM3, CHRM5, EDNRA |
3.47584 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA4, CA7, CA9, GLO1, MMP1, MMP2, MMP9, PPARA, PTPN1, RORC |
3.47326 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.47326 |
[MF] GO:0042578 |
None
|
ADORA1, ALPL, APEX1, CDC25B, CHRM1, CHRM3, CHRM5, EDNRA, PTPN1 |
3.31764 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX5, APEX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HSD17B1, HSD17B2, TYR, XDH |
3.2291 |
[MF] GO:0005230 |
None
|
CHRNA3, CHRNA7, GRIA2, GRIA4, GRIK5 |
3.14062 |
[MF] GO:0016788 |
None
|
ACHE, ADORA1, ALPL, APEX1, CA1, CA2, CDC25B, CHRM1, CHRM3, CHRM5, EDNRA, PTPN1 |
3.1085 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.04517 |
[MF] GO:0099528 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
2.97668 |
[MF] GO:0005506 |
iron ion binding
|
ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, XDH |
2.71835 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
2.71104 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, TYR |
2.69331 |
[MF] GO:0004620 |
None
|
ADORA1, CHRM1, CHRM3, CHRM5, EDNRA |
2.55967 |
[MF] GO:0004930 |
None
|
ADORA1, ADORA3, CHRM1, CHRM2, CHRM3, CHRM5, EDNRA, GRM1, GRM3, GRM5, GRM8, HCAR2 |
2.54398 |
[MF] GO:0042165 |
neurotransmitter binding
|
ACHE, CHRM3, CHRNA3, CHRNA7 |
2.48888 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.4556 |
[MF] GO:0004970 |
None
|
GRIA2, GRIA4, GRIK5 |
2.42603 |
[MF] GO:0005234 |
None
|
GRIA2, GRIA4, GRIK5 |
2.42603 |
[MF] GO:0032450 |
None
|
GAA, MGAM |
2.42603 |
[MF] GO:0099583 |
None
|
GRM1, GRM5 |
2.42603 |
[MF] GO:0008227 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
2.38415 |
[MF] GO:0016298 |
None
|
ADORA1, CHRM1, CHRM3, CHRM5, EDNRA |
2.20228 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, SRC |
2.1903 |
[MF] GO:0004971 |
None
|
GRIA2, GRIA4 |
2.18595 |
[MF] GO:0004558 |
None
|
GAA, MGAM |
2.18595 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, APEX1, CSNK2A1, FLT3, IGF1R, KDR, MMP9, PIM1, PPARA, PTPN1, SRC |
2.13451 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, HSD17B1, HSD17B2, XDH |
2.09338 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, SRC |
2.07744 |
[MF] GO:0015276 |
None
|
CHRNA3, CHRNA7, GRIA2, GRIA4, GRIK5 |
2.07207 |
[MF] GO:0022834 |
None
|
CHRNA3, CHRNA7, GRIA2, GRIA4, GRIK5 |
2.07207 |
[MF] GO:0070405 |
ammonium ion binding
|
ACHE, CHRM3, CHRNA3, CHRNA7 |
2.05596 |